Dialysis patients: new markers could predict heart and bone risks

NCT ID NCT07170761

Ongoing Knowledge-focused Sponsor: Medical University of Graz Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at 475 people on hemodialysis to find better markers for bone disease and blood vessel hardening. Researchers are checking if new markers can predict heart attacks, strokes, and death better than current tests. The goal is to improve monitoring and care for dialysis patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify better ways to monitor and predict heart and bone problems in dialysis patients.
What could go wrong: This is an observational study, not a treatment trial. It may not lead to any direct changes in patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CKD-MBD - CHRONIC KIDNEY DISEASE MINERAL AND BONE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

renal osteodystrophy vascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CKD-MBD - CHRONIC KIDNEY DISEASE MINERAL AND BONE DISORDER VASCULAR DISEASE

Contacts and locations

Locations

Medical University Graz

Graz, Styria, 8036, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.